<DOC>
	<DOCNO>NCT00264238</DOCNO>
	<brief_summary>The purpose study determine whether memantine safe effective use augmentation standard treatment Obsessive-Compulsive Disorder ( OCD ) .</brief_summary>
	<brief_title>Memantine Augmentation Obsessive-Compulsive Disorder</brief_title>
	<detailed_description>The purpose study determine whether memantine ( Namenda ) , dose 20 mg/day , effective treat OCD adult patient respond OCD medication . Memantine FDA approve OCD , approve treatment Alzheimer 's Disease . Memantine appear work regulate activity glutamate , one brain 's specialized messenger chemical , may play role OCD . All patient study receive memantine ; one receive placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>least 18 year age suffer OCD YBOCS score 18 great take therapeutic dose antiOCD medication specify protocol diagnose mental disorder OCD take tiagabine pregabalin previous trial memantine receive therapy OCD substance abuse last 6 month personality disorder sufficiently severe interfere study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>